Oculopharyngeal Muscular Dystrophy Ptosis, Mueller's Muscle Involvement, and a Review of Management Over 34 Years
- PMID: 35030153
- DOI: 10.1097/IOP.0000000000002118
Oculopharyngeal Muscular Dystrophy Ptosis, Mueller's Muscle Involvement, and a Review of Management Over 34 Years
Abstract
Purpose: To review the management of the ptosis associated with oculopharyngeal muscular dystrophy (OPMD) from one author's experience over 34 years, demonstrate Mueller's muscle involvement in this disease, and how this impacts the preferred choice of surgery.
Methods: Retrospective, nonrandomized comparative case series. Forty patients with OPMD who underwent primary bilateral ptosis surgery through an anterior eyelid incision and had their Mueller's muscle biopsied (one side) and sent for histopathologic analysis were selected for chart review. The main outcome measure was the presence or absence of dystrophic changes in the biopsied Mueller's muscle.
Results: In 29/40 biopsies (72.5%), there were dystrophic changes and fatty infiltration of Mueller's muscle identified histopathologically.
Conclusions: Mueller's muscle is involved in the dystrophic process more often than expected contributing to ptosis in the OPMD syndrome. A combined Mueller's-aponeurotic advancement is more effective at elevating the eyelid than simply advancing the aponeurosis when Mueller's is fatty infiltrated at the time of external levator advancement surgery in our experience. Management strategies for ptosis surgery in OPMD are reviewed. The age of onset, levator muscle function, previous ptosis repair, how debilitated the patient is with their disease process systemically, as well as the presence of other eye problems (e.g., dry eye, prior glaucoma filtering procedures, history of corneal surgery, laser refractive procedure) are important clinical considerations in patients with OPMD.
Copyright © 2022 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.
Comment in
-
Re: "Oculopharyngeal Muscular Dystrophy Ptosis, Mueller's Muscle Involvement, and a Review of Management Over 34 Years".Ophthalmic Plast Reconstr Surg. 2023 Jul-Aug 01;39(4):395. doi: 10.1097/IOP.0000000000002451. Epub 2023 Jul 4. Ophthalmic Plast Reconstr Surg. 2023. PMID: 37413679 No abstract available.
References
-
- Taylor EW. Progressive vagus-glasopharyngeal paralysis with ptosis: contribution to group of family diseases. J Nerv Ment Dis. 1915;42:129–139.
-
- Amyot R. Hereditary, familial and acquired ptosis of late onset. Can Med Assoc J. 1948;59:434–438.
-
- Victor M, Hayes R, Adams RD. Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids. N Engl J Med. 1962;267:1267–1272.
-
- Barbeau A. The syndrome of hereditary late onset ptosis and dysphagia in French Canada In:Kuhn, E, ed. Symposium uber progressive Muskel-dystrophie. Springer-Verlag;1966:102–109.
-
- Johnson CC, Kuwabara T. Oculopharyngeal muscular dystrophy. Am J Ophthalmol. 1974;77:872–879.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
